Le Lézard
Classified in: Health, Science and technology, Business
Subjects: LIC, PET, ANW

The First & Only Diagnostic Test for Periodontal Disease in Pets Announces Distribution Partnership


EPiQ Animal Health Announces the Distribution of OraStripdx, the Only Rapid Diagnostic Test for Periodontal Disease. Partnership Increases Access to Better Preventive Oral Health Care for Millions of Pets.

LOUISVILLE, Ky., June 26, 2023 /PRNewswire-PRWeb/ -- OraStripdx, the revolutionary 10-second diagnostic test that detects periodontal disease in pets in its earliest stages, is now available to all authorized veterinary distributors and customers nationwide via a partnership with EPiQ Animal Health. EPiQ, which supplies products to nearly 100 percent of the veterinarians in the United States through its channel partners, will significantly increase access to OraStripdx, allowing veterinarians to more effectively detect and prevent periodontal disease, a malady that affects more than 80 percent of adult pets.

"As the first rapid test for diagnosing early-stage periodontal disease, we're proud to be partnering with a company that has such a strong record promoting innovative products that improve pet health," said John Beran, CEO of PDX BIOTECH, the company that invented and manufactures OraStripdx. "EPiQ is the ideal partner who can help increase access to OraStripdx through more than 700 point-of-service industry sales representatives and 300 internal sales support staff. EPiQ is uniquely qualified to provide blanket coverage for our product, helping veterinarians and pet owners take action sooner rather than later to prevent more serious disease and dental interventions."

OraStripdx is the only rapid test that can detect active periodontal disease in dogs and cats in 10 seconds, with no anesthesia or sedation required. Each easy-to-use test strip changes color based on the concentration of thiols in the patient's oral fluid. When a veterinarian or technician glides OraStripdx along the gumline of a dog or cat, thiols in the oral fluid will cause the test strip to change color, with the concentration of thiols reflecting periodontal disease activity.

"We look forward to partnering with PDX BIOTECH and being their master distributor for OraStripdx in the animal health space," said Anje English, director of operations and commercial strategy, EPiQ Animal Health.

Periodontal disease is an invisible infection that causes needless suffering for millions of dogs and cats, so being able to test for it quickly and find it in its earliest stages is a major advantage to pet owners and their healthcare providers. In addition to periodontal disease itself causing pain, early detection can also serve as a warning sign of more serious diseases.

The performance of OraStripdx has been documented in peer-reviewed studies published in journals such as the Journal of the American Animal Hospital Association, the Journal of Veterinary Science & Technology and the Canadian Veterinary Journal. PDX BIOTECH has obtained five patents, and more than 750,000 tests have already been shipped to veterinary practices around the world. The partnership with EPiQ is expected to increase the distribution tenfold within the next year.

Veterinarians interested in learning more about and purchasing OraStripdx can reach out to EPiQ national sales managers, Anje English at [email protected] or (614) 763-2735 or Keely Burton at [email protected] or (561) 758-2335. More information can be found at http://www.orastripdx.com.

###

About EPiQ Animal Health
EPiQ Animal Health is a master distributor aiming to revolutionize the animal health industry through innovative supply chain and marketing solutions. The company partners with manufacturers to grow their brands and launch new products in the veterinary market. EPiQ's logistics and operations solutions streamline the supply chain for the manufacturer allowing them to focus on what they do best: innovating products. EPiQ's marketing solutions are consultative, comprehensive and strategic, and the company works with its partners to increase their brand awareness, generate demand and grow their revenue. Visit epiq-ah.com to learn more.

About OraStripdx and PDX BIOTECH
Manufactured in the U.S., OraStripdx is the premier product developed and produced by PDX BIOTECH, a growth-stage biotechnology company based in Louisville, Kentucky. The company is comprised of a core team of seasoned scientists and business leaders having over a century of combined experience, as well as an advisory board of global thought-leader veterinary clinicians. With the distribution of OraStripdx, PDX BIOTECH intends to contribute every day to the long-term health and wellness of pets and their families worldwide.

Media Contact
Beth Strautz
(773) 895-5387
[email protected]

Media Contact

Beth Strautz, Vagus PR, (773) 895-5387, beth@vaguspr.com

 

SOURCE Vagus PR


These press releases may also interest you

at 16:37
Hubble Network has achieved a monumental milestone: the first-ever Bluetooth connection directly to space. This landmark success follows the company's $20 million Series A funding round led by Transpose Platform and Y Combinator. The investment...

at 16:35
Innovid Corp. (the "Company"), a leading software platform for the creation, delivery, measurement, and optimization of advertising across connected TV (CTV), linear TV, and digital, today announced that management will participate in the following...

at 16:35
Apple® today announced financial results for its fiscal 2024 second quarter ended March 30, 2024. The Company posted quarterly revenue of $90.8 billion, down 4 percent year over year, and quarterly earnings per diluted share of $1.53. "Today Apple...

at 16:35
KLDiscovery Inc. ("KLDiscovery" or the "Company"), a global leader in data management, information governance, eDiscovery, and advisory services solutions, today announced that it has reached an agreement in principle with its principal convertible...

at 16:34
KAP Project Services, the leader in technology-enabled project controls solutions, proudly announces recognition as a trusted industry digital transformation solution provider by CruzAlta, a global firm specializing in operations performance...

at 16:33
Record First Quarter 2024 Revenue of $2.7 BillionFirst Quarter 2024 GAAP Net Loss of $34.5 Million, a $46.0 Million Improvement over First Quarter 2023 and Beating Consensus Estimates by $33.1 MillionFirst Quarter 2024 Adjusted EBITDA of $157.3...



News published on and distributed by: